ATI RN
ATI Pharmacology Final Exam 1 Questions
Extract:
Question 1 of 5
When giving chemotherapy as cancer treatment, the nurse recognizes that toxicity to rapidly growing normal cells also occurs. Which rapidly growing normal cells are also harmed by chemotherapy? (Select all that apply.)
Correct Answer: A,C,D
Rationale: Chemotherapy targets rapidly dividing cells, including GI mucosa, hair follicles, and bone marrow.
Question 2 of 5
A client is receiving her third course of chemotherapy. What will the nurse teach her about managing stomatitis, an adverse effect of this drug involving inflammation of the oral mucosa?
Correct Answer: A
Rationale: Daily mouth examination helps monitor stomatitis progression and complications.
Question 3 of 5
The nurse is monitoring a client who has severe bone marrow suppression following antineoplastic drug therapy. Which is considered a principal early sign of infection?
Correct Answer: C
Rationale: In bone marrow suppression, low white blood cell counts lead to fever as a result of inflammatory markers against infection.
Question 4 of 5
A nurse is reviewing the medical record of a client who just returned to the unit following surgery and notes the client has a history of anaphylaxis in response to penicillin. The client's postoperative prescriptions include a dose of cephalexin. Which of the following actions should the nurse take?
Correct Answer: C
Rationale: The client is at risk of a life-threatening anaphylaxis as cross reactivity occurs between cephalosporin and penicillin as they both contain a beta lactam ring. Cephalexin should be avoided completely.
Question 5 of 5
A client with oliguria has an order for 1000 mL of 0.9% NS over 3 hours. The tubing drop factor is 10 gtt/mL. How many gtt/min should be given? (Round to the nearest whole number. use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: A
Rationale: Flow rate (gtt/min) = Volume (mL)/Time (min) × Drop factor (gtts/mL) = 1000/180 × 10 = 56 gtt/min.